3.25
price up icon0.31%   0.02
 
loading
前日終値:
$3.23
開ける:
$3.27
24時間の取引高:
41,945
Relative Volume:
0.57
時価総額:
$1.15B
収益:
$842.96M
当期純損益:
$-185.63M
株価収益率:
-6.1799
EPS:
-0.5259
ネットキャッシュフロー:
$-228.52M
1週間 パフォーマンス:
-2.41%
1か月 パフォーマンス:
-23.04%
6か月 パフォーマンス:
-3.57%
1年 パフォーマンス:
-57.65%
1日の値動き範囲:
Value
$3.2235
$3.31
1週間の範囲:
Value
$3.1601
$3.37
52週間の値動き範囲:
Value
$2.85
$7.98

Evotec Se Adr Stock (EVO) Company Profile

Name
名前
Evotec Se Adr
Name
セクター
Healthcare (1161)
Name
電話
-
Name
住所
-
Name
職員
0
Name
Twitter
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
EVO's Discussions on Twitter

EVO を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
EVO
Evotec Se Adr
3.24 1.15B 842.96M -185.63M -228.52M -0.5259
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
159.99 73.88B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.18 48.17B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.46 47.59B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
14.81 17.28B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
307.32 13.78B 2.76B 1.11B 898.10M 22.77

Evotec Se Adr Stock (EVO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-10-07 ダウングレード Jefferies Buy → Hold
2024-08-08 ダウングレード Deutsche Bank Hold → Sell
2024-07-29 ダウングレード Morgan Stanley Overweight → Equal-Weight
2024-07-11 ダウングレード Deutsche Bank Buy → Hold
2024-04-12 アップグレード Deutsche Bank Hold → Buy
2024-01-18 アップグレード RBC Capital Mkts Sector Perform → Outperform
2023-06-23 アップグレード Morgan Stanley Equal-Weight → Overweight
2023-06-16 ダウングレード BofA Securities Buy → Neutral
2023-06-08 アップグレード Citigroup Neutral → Buy
2023-04-04 アップグレード Morgan Stanley Underweight → Equal-Weight
2022-12-09 開始されました H.C. Wainwright Buy
2022-11-16 ダウングレード Deutsche Bank Buy → Hold
2022-08-10 ダウングレード Morgan Stanley Overweight → Underweight
2022-03-02 再開されました Cowen Outperform
2022-01-07 再開されました Citigroup Neutral
すべてを表示

Evotec Se Adr (EVO) 最新ニュース

pulisher
Dec 29, 2024

Evotec: Some Recovery Has Come, But Much More Is Expected - Seeking Alpha

Dec 29, 2024
pulisher
Dec 27, 2024

Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid - MSN

Dec 27, 2024
pulisher
Dec 10, 2024

In-Vitro Toxicology Testing Market Projected to Reach USD 30.06 Bn by 2033 - GlobeNewswire Inc.

Dec 10, 2024
pulisher
Nov 25, 2024

Markets Brief: Are Bank Stocks Expensive? - Morningstar

Nov 25, 2024
pulisher
Nov 23, 2024

Evotec SE withdraws acquisition offer By Investing.com - Investing.com South Africa

Nov 23, 2024
pulisher
Nov 22, 2024

Evotec SE withdraws acquisition offer - Investing.com India

Nov 22, 2024
pulisher
Nov 22, 2024

Halozyme ends bid to acquire Evotec at €2 billion valuation - Investing.com

Nov 22, 2024
pulisher
Nov 18, 2024

Halozyme outlines plan to acquire Evotec for €2 billion - Investing.com

Nov 18, 2024
pulisher
Nov 18, 2024

Halozyme outlines plan to acquire Evotec for €2 billion By Investing.com - Investing.com UK

Nov 18, 2024
pulisher
Nov 17, 2024

Halozyme to Fund Proposed Evotec Takeover in Cash, CEO Says - Yahoo Finance

Nov 17, 2024
pulisher
Nov 15, 2024

Evotec SE responds to media speculation - Investing.com India

Nov 15, 2024
pulisher
Nov 15, 2024

Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion - AOL

Nov 15, 2024
pulisher
Nov 15, 2024

Halozyme Therapeutics sinks after confirming $2B Evotec buyout offer - Seeking Alpha

Nov 15, 2024
pulisher
Nov 15, 2024

Evotec SE responds to media speculation By Investing.com - Investing.com UK

Nov 15, 2024
pulisher
Nov 14, 2024

Halozyme proposes $2 billion acquisition of Evotec - Investing.com India

Nov 14, 2024
pulisher
Nov 08, 2024

Earnings call: Evotec SE maintains 2024 outlook amid strategic changes - Investing.com India

Nov 08, 2024
pulisher
Nov 07, 2024

Evotec SE ADR earnings beat by $0.02, revenue fell short of estimates - Investing.com

Nov 07, 2024
pulisher
Nov 07, 2024

Evotec Reports Strategic Growth Amidst Revenue Challenges - TipRanks

Nov 07, 2024
pulisher
Nov 05, 2024

Evotec SE Reports 9M 2024 Results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions - Yahoo Finance

Nov 05, 2024
pulisher
Oct 07, 2024

Evotec stock outlook clouded by strategy update delays, warns Jefferies - Investing.com

Oct 07, 2024
pulisher
Sep 23, 2024

KZIAKazia Therapeutics Limited American Depositary Shares Latest Stock News & Market Updates - StockTitan

Sep 23, 2024
pulisher
Aug 23, 2024

Stock Information - Evotec

Aug 23, 2024
pulisher
Aug 23, 2024

Annual General Meeting - Evotec

Aug 23, 2024
pulisher
Aug 23, 2024

Investor Relations - Evotec

Aug 23, 2024
pulisher
Aug 14, 2024

Bristol Myers' German Partner Evotec Plans Layoffs, Cites 'Challenging Revenues, Profitability' - Yahoo Finance

Aug 14, 2024
pulisher
Aug 13, 2024

Dozens of US Stocks Are Newly Undervalued After Market Selloff - Morningstar

Aug 13, 2024
pulisher
Aug 07, 2024

Evotec shares crash 36% on profit warning - Investing.com

Aug 07, 2024
pulisher
May 23, 2024

Earnings call: Evotec SE Q1 2024 results show mixed performance amid challenges - Investing.com

May 23, 2024
pulisher
Apr 08, 2024

T. Rowe Price Raises Stake in Evotec SE - TipRanks

Apr 08, 2024
pulisher
Jan 21, 2012

Together for Medicines That MatterEvotec - Evotec

Jan 21, 2012
pulisher
May 11, 2010

Evotech and Roche subsidiary Genentech enter into drug discovery alliance - Proactive Investors USA

May 11, 2010
pulisher
Sep 09, 2009

Evotec and Biogen Idec in research agreement - Proactive financial news

Sep 09, 2009

Evotec Se Adr (EVO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$9.735
price down icon 9.70%
$31.69
price down icon 2.97%
$95.31
price down icon 2.00%
$8.525
price down icon 0.93%
$105.98
price down icon 1.57%
$307.16
price down icon 1.34%
大文字化:     |  ボリューム (24 時間):